Therefore, the underexpression of TOLLIP in the TMA group might have occurred during tumor immunoediting in the early stages of RCC when TOLLIP-mediated autophagy is still an efficient way of preserving the genome stability and preventing malignant transformation [63]. The gene discussed is TOLLIP; the disease is neoplasm.